Indian Government Slashes Cancer Drug Price by 86%

India’s National Pharmaceutical Pricing Authority (NPPA) has announced major price cuts for certain cancer drugs, up to 86 percent in some cases. This is the latest in a series of government price cuts that has reduced the costs of around 1,450 drugs since late 2016. The 86 percent cut is to Iressa, used primarily to treat breast and lung cancer. … Continue reading →